These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5707445)

  • 41. Transient beneficial effects of glutamate-aspartate-enriched cardioplegia on ventricular functions in coronary artery bypass grafting.
    Duman U; Dogan OF
    J Card Surg; 2006; 21(5):523-5. PubMed ID: 16948778
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of stabilized auricular fibrillation with venous infusion of ajmaline in high doses combined with potassium aspartate].
    Fabris C
    G Clin Med; 1968 May; 49(5):520-40. PubMed ID: 5745870
    [No Abstract]   [Full Text] [Related]  

  • 43. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients.
    Wolfe F; Michaud K
    J Rheumatol; 2004 Nov; 31(11):2115-20. PubMed ID: 15517621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effect of glutamic and aspartic acid on collateral circulation and oxygen tension in the myocardium].
    Sapozhkov AV
    Patol Fiziol Eksp Ter; 1968; 12(5):20-3. PubMed ID: 5747630
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical experimentation with calcium transport agents. Calcium DL, L-aspartate and calcium 9-aminoethyl phosphate, 2 powerful anti-inflammatory and antiallergic agents].
    Nieper HA
    Agressologie; 1966; 7(6):623-39. PubMed ID: 5985602
    [No Abstract]   [Full Text] [Related]  

  • 46. [Intravenous administration of ornithine aspartate to patients with hepatic diseases].
    Schäfer W
    Munch Med Wochenschr; 1968 Oct; 110(43):2521-5. PubMed ID: 5755238
    [No Abstract]   [Full Text] [Related]  

  • 47. Validated method for L-ornithine-L-aspartate analysis in human plasma by capillary electrophoresis.
    Kowalski P; Bieniecki M; Oledzka I; Lamparczyk H
    Biomed Chromatogr; 2006 Feb; 20(2):185-94. PubMed ID: 16078310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical study results with a new active substance combination in geriatrics].
    Heinitz M
    Med Welt; 1969 May; 19():1144-7. PubMed ID: 5795618
    [No Abstract]   [Full Text] [Related]  

  • 49. [Exhaustion and fatigue--a neglected problem in hematologic oncology].
    Zahner J; Meran J; Karthaus M
    Wien Med Wochenschr; 2001; 151(3-4):89-93. PubMed ID: 11789424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Radiophysical studies: irradiation of ornithine aspartate in the Siemens training reactor SUR 100].
    Szirmai J; Knapp J; Keinert J
    Acta Oncol (Madr); 1969; 8(2):172-4. PubMed ID: 5385130
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use of ornithine alpha-ketoglutarate in malnourished cancer patients].
    Filoche B; Lefebvre V; Herlin F
    Med Chir Dig; 1982; 11(3):223-5. PubMed ID: 6808262
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pathophysiology and therapy of magnesium deficiency in pregnancy].
    Bartl W; Riss P
    Z Geburtshilfe Perinatol; 1982; 186(6):335-7. PubMed ID: 6891868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [On the irregular course of the alarm reaction in lympho-epithelial and lympho-reticular tissues under the effect of K-Mg-aspartate].
    Vasků J; Urbánek E; Dolezel S
    Arzneimittelforschung; 1966 Apr; 16(4):559-65. PubMed ID: 6014271
    [No Abstract]   [Full Text] [Related]  

  • 54. [Lipotropic effect of betaine aspartate on experimental hepatic steatosis. Study using triolein-C14].
    Perrault M; Dormard Y
    Therapie; 1966; 21(3):719-31. PubMed ID: 5942137
    [No Abstract]   [Full Text] [Related]  

  • 55. Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation.
    Schulze A; Ebinger F; Rating D; Mayatepek E
    Mol Genet Metab; 2001 Dec; 74(4):413-9. PubMed ID: 11749046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevention of potassium deficiency in long-term therapy with corticosteroids].
    Bolcskei P; Bopp KP
    Med Welt; 1969 May; 20():1177-80. PubMed ID: 5809500
    [No Abstract]   [Full Text] [Related]  

  • 57. Ornithine oxoglutarate improved nutrition in elderly patients.
    Jeevanandam M
    ACP J Club; 1995; 123(2):56. PubMed ID: 7655786
    [No Abstract]   [Full Text] [Related]  

  • 58. Fatigue in individuals with advanced cancer in active treatment and palliative settings.
    Olson K; Krawchuk A; Quddusi T
    Cancer Nurs; 2007; 30(4):E1-10. PubMed ID: 17666968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alternative pathway therapy for hyperammonemia in liver failure.
    Larsen FS; Wendon J
    Hepatology; 2009 Jul; 50(1):3-5. PubMed ID: 19441099
    [No Abstract]   [Full Text] [Related]  

  • 60. Physiological and biochemical evaluation of potential antifatigue drugs. I. The effects of aspartic acid salts (Mg and K) on the performance of men.
    CONSOLAZIO CF; NELSON RA; MATOUSH LO; ISAAC GJ
    Rep US Army Med Res Nutr Lab Denver; 1963 Mar; ():25p. PubMed ID: 14022659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.